Poly, T.N.; Islam, M.M.; Walther, B.A.; Lin, M.-C.; Li, Y.-C.
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals. Cancers 2022, 14, 5357.
https://doi.org/10.3390/cancers14215357
AMA Style
Poly TN, Islam MM, Walther BA, Lin M-C, Li Y-C.
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals. Cancers. 2022; 14(21):5357.
https://doi.org/10.3390/cancers14215357
Chicago/Turabian Style
Poly, Tahmina Nasrin, Md. Mohaimenul Islam, Bruno Andreas Walther, Ming-Chin Lin, and Yu-Chuan (Jack) Li.
2022. "Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals" Cancers 14, no. 21: 5357.
https://doi.org/10.3390/cancers14215357
APA Style
Poly, T. N., Islam, M. M., Walther, B. A., Lin, M.-C., & Li, Y.-C.
(2022). Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals. Cancers, 14(21), 5357.
https://doi.org/10.3390/cancers14215357